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Abstract
Several papers are discussed including the CARP (Coronary
Artery Revascularisation Prophylaxis) trial, examining the role, if
any, of preoperative coronary revascularisation and a study
examining the heart rate in the intensive care unit (ICU) population.
We also take a look at infections in the ICU with particular regard
to a recent study which examined isolating patients with methicillin-
resistant Staphylococcus aureus (MRSA).
“Pursue him to his house, and pluck him thence;
Lest his infection, being of catching nature,
Spread further.”
William Shakespeare (1608),
Coriolanus, act III, scene i
Once we were pursued to our own house and left to our own
devices but we now find ourselves venturing outside our units
and beyond. The role of the critical care physician is ever
evolving. Not least among these new tasks is the pre-
assessment and optimization of the high-risk surgical patient.
The assessment of such patients often leads to a dilemma
regarding how far to investigate them. This is particularly
pertinent in those awaiting vascular surgery, given their high
prevalence of coexistent coronary artery disease. The
question of which patients should be considered for coronary
artery revascularization preoperatively often provokes much
debate. This question has in part been answered by the
CARP (Coronary Artery Revascularisation Prophylaxis trial)
study, conducted by McFalls and coworkers [1]. Coronary
angiography was performed in patients awaiting vascular
surgery (either aortic aneurysm repair or arterial occlusive
disease of the legs) if they were deemed to be at increased
risk for a perioperative complication on the basis of clinical
risk factors and the presence or absence of myocardial
ischaemia on noninvasive stress imaging.
Patients were eligible for inclusion in the study if the coronary
angiogram showed a stenosis of ≥70% in at least one major
coronary artery. Those patients in whom ≥50% stenosis of
the left main coronary, left ventricular ejection fraction <20%,
or severe aortic stenosis was found were excluded from
randomization because of the proven benefit from
intervention. Of the 5859 patients awaiting surgery, 80%
were initially excluded because of insufficient cardiac risk,
previous coronary intervention without ischaemia, severe
coexisting illness, or urgent need for surgery. Interestingly,
patient refusal or participation in other studies accounted for
just under 11% of exclusions. Of the 1190 remaining patients
who underwent angiography, 680 were subsequently
excluded: 73 patients satisfied the exclusion criteria
mentioned above, 363 had nonobstructive disease and 215
did not have disease amenable to revascularization; a further
29 patients refused to participate. Thus, 510 patients were
randomized: 258 to preoperative revascularization (either
percutaneous coronary intervention or bypass surgery) and
252 to medical therapy.
There were no differences between those who had
undergone revascularization and the control group in terms of
death rates, myocardial infarction, or length of hospital stay,
although the median time to surgery following randomization
was significantly different between groups (18 days in the
control group versus 54 days in those undergoing revas-
cularization). No long-term benefits during the follow-up
period were demonstrated.
Criticism could be aimed at the relatively short period
between revascularization and further operative intervention,
which might have negated any potential benefit. However, in
many cases delaying any definitive operative procedure for
more than 6 months, for example, is not practical and may be
associated with increased mortality from the underlying
condition. Does this study help in our preoperative
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assessment? Well, it does, probably. It tells us that elective
coronary artery revascularization in patients with stable
disease is of limited value, given the exclusion criteria noted,
which is in keeping with current opinion [2]. Unfortunately, it
does not tell us which patients to screen. We await further
studies to help guide us in that respect.
When faced with a high-risk patient postoperatively on the
ICU, we are armed with an impressive array of technologies
to monitor their progress. A study published in Critical Care
Medicine [3] reported on the monitoring of that most vital of
signs – the heart rate. Over a 12-month period patients
identified as being at high risk of cardiac complications (both
medical and surgical) were studied, and the investigators
demonstrated that prolonged periods of persistently raised
heart rate (>95 beats/min for >12 hours) was associated
with increases in both major cardiac events and length of
stay. Although more patients in the control group were on
preoperative  β-blockade, this difference only just achieved
statistical significance. Interestingly, significantly more
patients in the control group were admitted electively. There
was a significant increase in new onset supraventricular
arrythmias, with over 50% of patients with elevated heart rate
developing new-onset atrial fibrillation, and this appeared to
precede the cardiac events. We should remember to pay
attention to the top line of our monitors!
Most ‘high-risk intensive care patients will of course have
central venous access, and we are all aware of the dangers
inherent in this practice, not least that of catheter-related
infection. Deshpande and coworkers [4] reported an
interesting study on the incidence of infectious complications
at various sites of central access. They prospectively studied
the incidence of catheter-related infections and colonization
at the internal jugular, subclavian and femoral sites. The
results make interesting reading, not least because of the
overall low incidence of infections, but also in that there was
no observed statistically significant difference between the
sites in terms of infection. However, the overall trend
suggested that the femoral site was the least preferable
choice, given that the overall incidences of infection/1000
catheter-days were 0% for internal jugular, 0.45% for
subclavian and 1.44% for femoral sites. This is in keeping
with a randomized controlled trial [5] that demonstrated an
increased incidence in infection when the femoral site was
used as compared with the subclavian route.
Given the low overall infection rate, the authors should be
congratulated on such good clinical practice. This is a point
echoed by Berenholtz and coworkers [6], who reported that
catheter-related infections were reduced to zero by a simple
mix of staff education, deployment of a vascular access cart,
daily assessment of the line, a check list to ensure sterile
technique, and the ability of the nurse to halt the procedure if
sterility was compromised. This nirvana was achieved by hard
work and is what we should all be aiming for, especially
because of the hazards associated with hospital-acquired
infections and, in particular, those caused by methicillin-
resistant Staphylococcus aureus (MRSA).
Once MRSA is identified in any of our patients, much effort
is expended in order to try to minimize spread. Although the
wearing of gloves and gowns together with adequate hand
hygiene is encouraged, many units also ‘isolate’ infected or
colonized patients in order to reduce spread. This practice is
often complex and can involve several bed swaps. Moreover,
in some cases it may result in closure of that limited
resource, the ICU bed. To this end the study conducted by
Cepeda and coworkers [7] is useful. They undertook a
prospective 1-year study in two intensive care units. All
patients requiring intensive care for more than 48 hours
were included from two teaching hospital units. The study
was elegantly designed, consisting of three phases: phase 1
(first 3 months), phase 2 (middle 6 months) and phase 3
(last 3 months). In phases 1 and 3 any patient colonized or
infected with MRSA was moved to a single room or cohort
isolated. In phase 2 such patients were only moved if they
were carrying other multiresistant pathogens or for other
reasons such as neutropenia. There was no difference in
other standard and contact precautions, including apron
wearing, glove usage and hand hygiene. A total of 866
patients were included in the study, with 168 patients MRSA
positive on admission (although screening cultures were
available in only 80–87%) and 96 patients acquired MRSA
during their stay.
There were no observed differences between phases,
implying that moving MRSA-positive patients did not reduce
cross-infection in this environment. As the authors rightly
point out, isolation of critically ill patients is potentially
hazardous and more effective means of preventing spread of
MRSA in settings where it is endemic must be found. Rather
than spending our time moving our patients, we should
concentrate more on essential infection control practices.
This was highlighted in this study, in which compliance with
hand hygiene in those nurses dealing with high-risk patients
was 21%. The data for the clinicians were not presented, but
one would hope that this was better!
Finally, given this report on ‘superbugs’, we turn our
attentions to the Superbowl. A study reported in the New
England Journal of Medicine [8] examined an outbreak of
MRSA infections in players of the St Louis Rams football
team. Of the squad, 9% developed MRSA infections at turf
abrasion sites; 42% of staff and players had MRSA isolated
from nasal swabs. The players who developed abscesses
were those involved in frequent contact as opposed to those
in the backfield. Several other factors were also deemed to
be relevant, including not showering before using communal
whirlpools and the sharing of towels, both of which – as far
as we are aware – are uncommon ICU practices. There was
one common theme, however – a lack of regular access to133
hand hygiene for trainers who provided wound care. We
should all remember that. Now, go and wash your hands!
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